Pre-Dialysis Kidney Disease Market Heats Up With Oral Zemplar NDA, Hectorol Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
Bone Care International's launch of the first vitamin D compound approved for secondary hyperparathyroidism in pre-dialysis patients (Hectorol) coincides with Abbott's NDA filing for Zemplar capsules.